Overview

Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic Subjects

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
Once a day oral administration with DCCR is the optimal dosing regimen
Phase:
Phase 1
Details
Lead Sponsor:
Essentialis, Inc.
Collaborator:
Cetero Research, San Antonio
Treatments:
Choline
Diazoxide